Study on the application of intravenous lidocaine in hysteroscopy: a randomized controlled trial.

Study on the application of intravenous lidocaine in hysteroscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033551

Enrollment

Unknown

Registered

2020-06-05

Start date

2020-06-15

Completion date

Unknown

Last updated

2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulterine diseases

Interventions

experimental group:Lidocaine

control group:Normal saline

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective hysteroscopic surgery requiring intravenous general anesthesia, ASA grade 1-2, aged 20-40 years, BMI 18-24kg/m2.

Exclusion criteria

Exclusion criteria: Past birth history; abnormal liver and kidney function; history of cardiopulmonary disease; sleep apnea syndrome; long-term use of diazepam and other drugs; long-term use of opioids; lidocaine allergy.

Design outcomes

Primary

Measure	Time frame
CP50;	—

Secondary

Measure	Time frame
Cp95;Total demand for Propofol for surgery;	—

Countries

China

Contacts

Public ContactLili Xu

Women's Hospital School of Medicine Zhejiang University

xulili1202@126.com+86 18268144502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026